Form 4 for BBIO BridgeBio Pharma, Inc.
Accepted 2025-03-21 00:00:00 ET · period of report 2025-03-19 · accession 0000950170-25-043403 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-21 | 2025-03-19 | BBIO | Trimarchi Thomas | Pres, CFO | A - Grant | $0.00 | +109.1K | 523.3K | +26% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-19 | A | A | 109,100 | $0.00 | 523,305 | D | — | — | (F2) Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. |